Trial Profile
A study to assess the efficacy, safety, pharmacokinetics and related genetic polymorphisms of afatinib
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2014
Price :
$35
*
At a glance
- Drugs Afatinib (Primary)
- Indications Lung cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 16 Sep 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 14 Jul 2014 New trial record